Adaptive TCR corporation: service contract for 40,000 input genomes, and 200,000 TCR sequences survey

Ended Purchase Order Awarded Last action

Contract number
HHSN261201400379P
Awardee
Awarding agency
Obligated
$197,125

Award facts

Opportunity
Contract value 100% obligated
$197,125.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$2,875
Other Administrative Action 1 $0
Original award $200,000

About this award

The National Cancer Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $197,125 on July 22, 2014, covering service delivery of 40,000 input genomes and 200,000 TCR sequences survey work. Place of performance is Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of April 23, 2019.

Quick answers

Who was awarded contract HHSN261201400379P?

HHSN261201400379P was awarded to Adaptive Biotechnologies Corporation by National Cancer Institute (National Institutes of Health) on July 22, 2014.

How much is contract HHSN261201400379P worth?

The government has obligated $197,125 on HHSN261201400379P.

Was contract HHSN261201400379P competed?

The extent of competition for HHSN261201400379P was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award